MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,058.18 +37.34 (+3.66%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,887,170
Open 1,056.00
Bid (Size) 1,068.55 (80)
Ask (Size) 1,069.10 (40)
Prev. Close 1,020.84
Today's Range 1,033.27 - 1,060.02
52wk Range 623.78 - 1,133.95
Shares Outstanding 956,580,893
Dividend Yield 0.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HIMS Stock In Turmoil: Retail Bulls Bet On Rebound, Skeptics See Bloodbath After Compounded Weight-Loss Pill Halt ↗
Retail bulls pointed to similar price levels during high short interest in late 2024 and said ending compounded sales removes the risk of a costly legal fight. 
Via Stocktwits
Topics Intellectual Property Law Enforcement
News headline image
Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock? ↗
It doesn't look too late to buy the stock. 
Via The Motley Fool

Performance

YTD
-2.1%
-2.1%
1 Month
-0.5%
-0.5%
3 Month
+9.5%
+9.5%
6 Month
+66.6%
+66.6%
1 Year
+21.8%
+21.8%

More News

Read More
News headline image
Medicare Changes in 2026 Every Retiree Needs to Know: The Good, the Bad, and the Ugly ↗
Via The Motley Fool
Topics Economy Government Retirement
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Via The Motley Fool
News headline image
3 Things Investors Need to Know About the Healthcare Sector in 2026 ↗
Via The Motley Fool
Topics Economy
News headline image
1 Brilliant Vanguard Index Fund to Buy Before It Soars 120%, According to a Wall Street Analyst ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut ↗
Via MarketBeat
News headline image
Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
Via MarketMinute
Topics Earnings Economy
News headline image
AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Biogen (BIIB) Q4 Earnings Preview: The "New Biogen" Emerges as Alzheimer's and Rare Disease Pipelines Take Center Stage
Via MarketMinute
Topics Intellectual Property
News headline image
Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore ↗
Via The Motley Fool
News headline image
The $49 Disruptor: Hims & Hers Ignites a Brutal Price War in the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
What Does the Market Think About Eli Lilly and Co? ↗
Via Benzinga
News headline image
Why Shares of Novo Nordisk Stock Collapsed This Week ↗
Via The Motley Fool
News headline image
The Trillion-Dollar Divergence: Eli Lilly Hits Milestone While Novo Nordisk Faces 'Supply Chain Reset'
Via MarketMinute
Topics Economy
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
Via Finterra
Topics Economy Government Intellectual Property
News headline image
Biogen (BIIB) Deep Dive: Navigating the Pivot from MS Giant to Neuro-Innovation Powerhouse
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
The $180 Billion Gamble: Alphabet’s High-Stakes AI Transformation in 2026
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
These S&P500 stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
Walmart Just Became the Newest Member of the Trillion-Dollar Club, and These 2 Non-AI Stocks May Be Next -- but There's a Catch ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Government
News headline image
Eli Lilly Stock Has Over 20% Upside, Analysts Say: Retail Seeks Pharma 'Safe Haven' As FDA Targets GLP-1 Copycats ↗
Via Stocktwits
Topics Fraud Law Enforcement
News headline image
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. ↗
Via The Motley Fool
News headline image
The Great Rebalancing: Why Investors are Fleeing Big Tech for the 'Safety' of Utilities and Healthcare
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most ↗
Via MarketBeat

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,058.18
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 02/06/26 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,012.23B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,012B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story